Dongsung Pharm - Asset Resilience Ratio

Latest as of March 2025: 0.00%

Dongsung Pharm (002210) has an Asset Resilience Ratio of 0.00% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩-1.00K

≈ $-0.68 USD Cash + Short-term Investments

Total Assets

₩168.60 Billion

≈ $114.26 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2022)

This chart shows how Dongsung Pharm's Asset Resilience Ratio has changed over time. Check 002210 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Dongsung Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002210 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩-1.00K	-0.0%
Total Liquid Assets	₩-1.00K	0.00%

Asset Resilience Insights

Limited Liquidity: Dongsung Pharm maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Dongsung Pharm Industry Peers by Asset Resilience Ratio

Compare Dongsung Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Dongsung Pharm (2008–2022)

The table below shows the annual Asset Resilience Ratio data for Dongsung Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	₩-300.00 ≈ $-0.20	₩107.70 Billion ≈ $72.99 Million	-1.91pp
2021-12-31	1.91%	₩2.00 Billion ≈ $1.36 Million	₩104.58 Billion ≈ $70.87 Million	-5.30pp
2020-12-31	7.22%	₩9.07 Billion ≈ $6.15 Million	₩125.72 Billion ≈ $85.20 Million	-6.89pp
2019-12-31	14.10%	₩18.58 Billion ≈ $12.59 Million	₩131.73 Billion ≈ $89.27 Million	-7.31pp
2018-12-31	21.41%	₩30.02 Billion ≈ $20.34 Million	₩140.20 Billion ≈ $95.01 Million	+10.23pp
2017-12-31	11.18%	₩13.88 Billion ≈ $9.41 Million	₩124.18 Billion ≈ $84.16 Million	-2.59pp
2016-12-31	13.76%	₩17.26 Billion ≈ $11.70 Million	₩125.39 Billion ≈ $84.97 Million	+13.14pp
2011-12-31	0.62%	₩774.12 Million ≈ $524.61K	₩124.58 Billion ≈ $84.42 Million	-1.17pp
2010-12-31	1.79%	₩2.29 Billion ≈ $1.55 Million	₩127.81 Billion ≈ $86.61 Million	-1.96pp
2009-12-31	3.75%	₩4.79 Billion ≈ $3.25 Million	₩127.91 Billion ≈ $86.68 Million	+3.42pp
2008-12-31	0.33%	₩405.00 Million ≈ $274.46K	₩124.57 Billion ≈ $84.42 Million	--

pp = percentage points

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Million

₩23.75 Billion KRW

Market Cap Rank

#25746 Global

#1908 in Korea

Share Price

₩973.00

Change (1 day)

+0.00%

52-Week Range

₩973.00 - ₩973.00

All Time High

₩45800.00